[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @MSollender Michelle Solly Michelle Solly posts on X about $cytk, $rare, $atai, atai life the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::1063180083769176064/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX +35% - X Months XXXXXXXXX +18% - X Year XXXXXXXXX +1,568% ### Mentions: XX [#](/creator/twitter::1063180083769176064/posts_active)  - X Month XX -XX% - X Months XXX +7.50% - X Year XXX +1,339% ### Followers: XXXXXX [#](/creator/twitter::1063180083769176064/followers)  - X Week XXXXXX +0.33% - X Month XXXXXX +1.40% - X Months XXXXXX +3.90% - X Year XXXXXX +7.90% ### CreatorRank: XXXXXXX [#](/creator/twitter::1063180083769176064/influencer_rank)  ### Social Influence [#](/creator/twitter::1063180083769176064/influence) --- **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [cryptocurrencies](/list/cryptocurrencies) **Social topic influence** [$cytk](/topic/$cytk), [$rare](/topic/$rare), [$atai](/topic/$atai), [atai life](/topic/atai-life), [$capr](/topic/$capr), [$abvx](/topic/$abvx) #3, [investment](/topic/investment), [$apls](/topic/$apls), [$gern](/topic/$gern), [acquisition](/topic/acquisition) **Top assets mentioned** [Cytokinetics Inc. (CYTK)](/topic/$cytk) [SuperRare (RARE)](/topic/$rare) [ATAI Life Sciences (ATAI)](/topic/$atai) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls) [Geron Corp (GERN)](/topic/$gern) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Incyte Corporation (INCY)](/topic/$incy) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Radio Caca (RACA)](/topic/$raca) [Taraxa (TARA)](/topic/$tara) [Pfizer, Inc. (PFE)](/topic/$pfe) [Illumina, Inc. (ILMN)](/topic/$ilmn) [Guardant Health, Inc. Common Stock (GH)](/topic/$gh) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) ### Top Social Posts [#](/creator/twitter::1063180083769176064/posts) --- Top posts by engagements in the last XX hours "$ATAI atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1939992011496624461) 2025-07-01 10:18:33 UTC 13.1K followers, 1982 engagements "$ATAI atai Life Sciences Announces $XX Million Private Placement Financing Ferring Ventures S.A. and Apeiron Investment Ltd. with Ally Bridge Group and ADAR1"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1939992129042067509) 2025-07-01 10:19:01 UTC 13.1K followers, 3185 engagements "Varda Announces $XXX million in Series C Funding to Make Medicines in Space Can't we just make them on Earth first"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1943265903975780795) 2025-07-10 11:07:50 UTC 13.1K followers, 22.8K engagements "$APLS Apellis to Receive up to $XXX Million from Royalty Purchase Agreement with Sobi forEx-U.S. Royalties of Aspaveli (systemic pegcetacoplan)"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1940003228596453848) 2025-07-01 11:03:07 UTC 13.1K followers, 2557 engagements "$GERN Geron Announces FDA Approval of RYTELO (imetelstat) a First-in-Class Telomerase Inhibitor for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1798898822426525832) 2024-06-07 02:04:35 UTC 13.1K followers, 14.7K engagements "$ARYBU Perceptive SPAC: Cerevel Therapeutics and Arya Sciences Acquisition Corp II Announce Business Combination Creating a Publicly Listed Leader in Neuroscience Drug Development"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1288792837899743233) 2020-07-30 11:05:31 UTC 13.1K followers, XX engagements "$SRPT Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term Sustainable Growth and Provides Update on ELEVIDYS Label"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1945575395128217899) 2025-07-16 20:04:55 UTC 13.1K followers, 14.4K engagements "$CYTK Cytokinetics submitted the NDA for aficamten in oHCM without an accompanying REMS and the FDA accepted the NDA for filing. Recently during the NDA review the FDA requested that Cytokinetics submit a REMS Oh"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1918041002880749854) 2025-05-01 20:33:05 UTC 13.1K followers, 8301 engagements "$MREO $RARE Ultragenyx and Mereo BioPharma Announce UX143 Phase X Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1943039211726344343) 2025-07-09 20:07:02 UTC 13.1K followers, 16.6K engagements "$CAPR Well that one didn't work out nearly as well as I wanted to as a trade but the obvious outcome was the obvious outcome ✅"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1943666034134929456) 2025-07-11 13:37:48 UTC 13.1K followers, 5676 engagements "$KYMR Interesting Kymera had decided last year not to advance their previous oncology pipeline past Ph1 (MDM2 and STAT3) but now has entered into a collaboration with $GILD for CDK2 degraders $85m upfront up to $750m in milestones"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1937945753194008782) 2025-06-25 18:47:27 UTC 13.1K followers, 5464 engagements "(2/3) Here are some slated for 2H25 Those that are specifically in 4Q25 are not listed yet $BIOA $CABA $CNTA $DRUG"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1940005635040620615) 2025-07-01 11:12:41 UTC 13.1K followers, 3655 engagements "$CYTK Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy DEC XX 2025"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1918037054149320977) 2025-05-01 20:17:23 UTC 13.1K followers, 10.6K engagements "$INCY Incyte Appoints Bill Meury Chief Executive Officer; Herv Hoppenot to Retire Previously of Karuna Therapeutics Julian Baker elected Chairman of the Board of Directors"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1938199599522746422) 2025-06-26 11:36:09 UTC 13.1K followers, 8307 engagements "$BMY Bristol Myers Squibb Announces Topline Results from Phase X ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia Fail"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1914776634768695563) 2025-04-22 20:21:39 UTC 13.1K followers, 3471 engagements "$ABVX Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 Enhancer in Moderate to Severely Active Ulcerative Colitis"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1947751594671673714) 2025-07-22 20:12:22 UTC 13.1K followers, 10.9K engagements "Cormorant 3Q20 BUYS (2/2): NEW: $ITOS +350000 (0.33% of book) $TARA +450000 (0.29%) $MORF +250000 (0.26%) $OTIC +3241800 (0.50%) $TCRR +600000 (0.47%) SPACs: $RACA $PANAU $HSAQ $BCTG $FSDC $VSPRU"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1328454388680060929) 2020-11-16 21:46:22 UTC 13.1K followers, XX engagements "$PFE Pfizer Enters into Exclusive Licensing Agreement with 3SBio SSGJ-707 a bispecific antibody targeting PD-1 and VEGF Upfront payment of $XXXX billion and milestones up to $XXX billion"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1924617438211277122) 2025-05-20 00:05:29 UTC 13.1K followers, 58.2K engagements "RTW 3Q20 13F BUYS (2/3): NEW: $TRIL +2160800 (0.74% of book) $IMUX +912496 (0.41%) $VXRT +3517345 (0.56%) $PMVP +500000 (0.43%) $GH +469498 (1.26%) $BLI +300338 (0.55%) $CYTK +2000000 (0.98%) $AFIB +451834 (0.32%) $ATHA +2668913 (1.09%) $ILMN +175000 (1.30%)"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1328436576964132865) 2020-11-16 20:35:35 UTC 13.1K followers, XX engagements "(1/3) Wow second half of the year already Here are some catalysts for 3Q25 Those in 4Q25 are not listed. The ones in the nice calming blue are those I have my eye on $ABUS $ABVX $AMLX $APGE $ATYR $CAPR $COGT $CRDF $FULC $KALA $MLTX $NEUP $OMER $RARE $REPL $SRRK $VYNE"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1940005423534547058) 2025-07-01 11:11:51 UTC 13.1K followers, 50K engagements "$RARE Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1943770441400955246) 2025-07-11 20:32:41 UTC 13.1K followers, 18.1K engagements "@jq1234t So does that mean if you're less than X month out and you haven't gotten a CRL you're approved 🤔"  [@MSollender](/creator/x/MSollender) on [X](/post/tweet/1943786169999012244) 2025-07-11 21:35:11 UTC 13.1K followers, 1513 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@MSollender Michelle Solly
Michelle Solly posts on X about $cytk, $rare, $atai, atai life the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX +35%
- X Months XXXXXXXXX +18%
- X Year XXXXXXXXX +1,568%
Mentions: XX #
- X Month XX -XX%
- X Months XXX +7.50%
- X Year XXX +1,339%
Followers: XXXXXX #
- X Week XXXXXX +0.33%
- X Month XXXXXX +1.40%
- X Months XXXXXX +3.90%
- X Year XXXXXX +7.90%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks finance cryptocurrencies
Social topic influence $cytk, $rare, $atai, atai life, $capr, $abvx #3, investment, $apls, $gern, acquisition
Top assets mentioned Cytokinetics Inc. (CYTK) SuperRare (RARE) ATAI Life Sciences (ATAI) Apellis Pharmaceuticals, Inc. Common Stock (APLS) Geron Corp (GERN) Sarepta Therapeutics, Inc. (SRPT) Gilead Sciences, Inc. (GILD) Kymera Therapeutics, Inc. Common Stock (KYMR) Incyte Corporation (INCY) Bristol-Myers Squibb Co (BMY) Radio Caca (RACA) Taraxa (TARA) Pfizer, Inc. (PFE) Illumina, Inc. (ILMN) Guardant Health, Inc. Common Stock (GH) Apogee Therapeutics, Inc. Common Stock (APGE) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Scholar Rock Holding Corporation Common Stock (SRRK)
Top Social Posts #
Top posts by engagements in the last XX hours
"$ATAI atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression"
@MSollender on X 2025-07-01 10:18:33 UTC 13.1K followers, 1982 engagements
"$ATAI atai Life Sciences Announces $XX Million Private Placement Financing Ferring Ventures S.A. and Apeiron Investment Ltd. with Ally Bridge Group and ADAR1" @MSollender on X 2025-07-01 10:19:01 UTC 13.1K followers, 3185 engagements
"Varda Announces $XXX million in Series C Funding to Make Medicines in Space Can't we just make them on Earth first" @MSollender on X 2025-07-10 11:07:50 UTC 13.1K followers, 22.8K engagements
"$APLS Apellis to Receive up to $XXX Million from Royalty Purchase Agreement with Sobi forEx-U.S. Royalties of Aspaveli (systemic pegcetacoplan)" @MSollender on X 2025-07-01 11:03:07 UTC 13.1K followers, 2557 engagements
"$GERN Geron Announces FDA Approval of RYTELO (imetelstat) a First-in-Class Telomerase Inhibitor for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia" @MSollender on X 2024-06-07 02:04:35 UTC 13.1K followers, 14.7K engagements
"$ARYBU Perceptive SPAC: Cerevel Therapeutics and Arya Sciences Acquisition Corp II Announce Business Combination Creating a Publicly Listed Leader in Neuroscience Drug Development" @MSollender on X 2020-07-30 11:05:31 UTC 13.1K followers, XX engagements
"$SRPT Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term Sustainable Growth and Provides Update on ELEVIDYS Label" @MSollender on X 2025-07-16 20:04:55 UTC 13.1K followers, 14.4K engagements
"$CYTK Cytokinetics submitted the NDA for aficamten in oHCM without an accompanying REMS and the FDA accepted the NDA for filing. Recently during the NDA review the FDA requested that Cytokinetics submit a REMS Oh" @MSollender on X 2025-05-01 20:33:05 UTC 13.1K followers, 8301 engagements
"$MREO $RARE Ultragenyx and Mereo BioPharma Announce UX143 Phase X Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis" @MSollender on X 2025-07-09 20:07:02 UTC 13.1K followers, 16.6K engagements
"$CAPR Well that one didn't work out nearly as well as I wanted to as a trade but the obvious outcome was the obvious outcome ✅" @MSollender on X 2025-07-11 13:37:48 UTC 13.1K followers, 5676 engagements
"$KYMR Interesting Kymera had decided last year not to advance their previous oncology pipeline past Ph1 (MDM2 and STAT3) but now has entered into a collaboration with $GILD for CDK2 degraders $85m upfront up to $750m in milestones" @MSollender on X 2025-06-25 18:47:27 UTC 13.1K followers, 5464 engagements
"(2/3) Here are some slated for 2H25 Those that are specifically in 4Q25 are not listed yet $BIOA $CABA $CNTA $DRUG" @MSollender on X 2025-07-01 11:12:41 UTC 13.1K followers, 3655 engagements
"$CYTK Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy DEC XX 2025" @MSollender on X 2025-05-01 20:17:23 UTC 13.1K followers, 10.6K engagements
"$INCY Incyte Appoints Bill Meury Chief Executive Officer; Herv Hoppenot to Retire Previously of Karuna Therapeutics Julian Baker elected Chairman of the Board of Directors" @MSollender on X 2025-06-26 11:36:09 UTC 13.1K followers, 8307 engagements
"$BMY Bristol Myers Squibb Announces Topline Results from Phase X ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia Fail" @MSollender on X 2025-04-22 20:21:39 UTC 13.1K followers, 3471 engagements
"$ABVX Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 Enhancer in Moderate to Severely Active Ulcerative Colitis" @MSollender on X 2025-07-22 20:12:22 UTC 13.1K followers, 10.9K engagements
"Cormorant 3Q20 BUYS (2/2): NEW: $ITOS +350000 (0.33% of book) $TARA +450000 (0.29%) $MORF +250000 (0.26%) $OTIC +3241800 (0.50%) $TCRR +600000 (0.47%) SPACs: $RACA $PANAU $HSAQ $BCTG $FSDC $VSPRU" @MSollender on X 2020-11-16 21:46:22 UTC 13.1K followers, XX engagements
"$PFE Pfizer Enters into Exclusive Licensing Agreement with 3SBio SSGJ-707 a bispecific antibody targeting PD-1 and VEGF Upfront payment of $XXXX billion and milestones up to $XXX billion" @MSollender on X 2025-05-20 00:05:29 UTC 13.1K followers, 58.2K engagements
"RTW 3Q20 13F BUYS (2/3): NEW: $TRIL +2160800 (0.74% of book) $IMUX +912496 (0.41%) $VXRT +3517345 (0.56%) $PMVP +500000 (0.43%) $GH +469498 (1.26%) $BLI +300338 (0.55%) $CYTK +2000000 (0.98%) $AFIB +451834 (0.32%) $ATHA +2668913 (1.09%) $ILMN +175000 (1.30%)" @MSollender on X 2020-11-16 20:35:35 UTC 13.1K followers, XX engagements
"(1/3) Wow second half of the year already Here are some catalysts for 3Q25 Those in 4Q25 are not listed. The ones in the nice calming blue are those I have my eye on $ABUS $ABVX $AMLX $APGE $ATYR $CAPR $COGT $CRDF $FULC $KALA $MLTX $NEUP $OMER $RARE $REPL $SRRK $VYNE" @MSollender on X 2025-07-01 11:11:51 UTC 13.1K followers, 50K engagements
"$RARE Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)" @MSollender on X 2025-07-11 20:32:41 UTC 13.1K followers, 18.1K engagements
"@jq1234t So does that mean if you're less than X month out and you haven't gotten a CRL you're approved 🤔" @MSollender on X 2025-07-11 21:35:11 UTC 13.1K followers, 1513 engagements